HIGH‐RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS. (June 2017) - Reagan, P.; Loh, K.P.; Baran, A.; Hu, J.; Casulo, C.; Barr, P.M.; Friedberg, J.W.